Active principles | Rating | Bibliogr. | Expand | |
---|---|---|---|---|
1 | Plague Vaccine | 100 | + | |
2 | Hemagglutinins, Viral | 15 | + | |
3 | Pore Forming Cytotoxic Proteins | 13 | + | |
4 | Viral Vaccines | 10 | + | |
5 | Viral Proteins | 9 | + | |
6 | Vaccines, Synthetic | 8 | + | |
7 | Glycoproteins | 5 | + | |
8 | Antibodies, Bacterial | 5 | + | |
9 | Antibodies, Viral | 5 | + | |
10 | Bacterial Proteins | 4 | + | |
11 | Vaccines, Subunit | 3 | + | |
12 | Vaccines, Attenuated | 2 | + | |
13 | Ivermectin | 2 | + | |
14 | Site-Specific DNA-Methyltransferase (Adenine-Specific) | 2 | + | |
15 | Pyrethrins | 1 | + | |
16 | Antigens, CD43 | 1 | + | |
17 | Anthrax Vaccines | 1 | + | |
18 | Recombinant Fusion Proteins | 1 | + | |
19 | Immunoglobulin G | 1 | + | |
20 | Phenanthridines | 1 | + | |
21 | Streptomycin | 1 | + | |
22 | Oxytetracycline | 1 | + | |
23 | Levofloxacin | 1 | + | |
24 | Bacterial Vaccines | 1 | + | |
25 | Tylosin | 1 | + | |
26 | Ofloxacin | 1 | + | |
27 | Fenbendazole | 1 | + | |
28 | Immunoglobulin A | 1 | + | |
29 | Salmonella Vaccines | 1 | + | |
30 | Vaccines, Inactivated | 1 | + | |
31 | Diminazene | 1 | + | |
32 | Monensin | 1 | + |